Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SAN FRANCISCO, NOV. 27, 2025 (GLOBE NEWSWIRE) -- MEDICAL DEVICE MANUFACTURER INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS THE SUBJECT OF A SECURITIES CLASS ACTION LAWSUIT FOLLOWING A SHARP DECLINE IN ITS STOCK PRICE, WITH SHAREHOLDERS ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE LAUNCH OF ITS LATEST PRODUCT, THE INSPIRE V DEVICE FOR OBSTRUCTIVE SLEEP APNEA. HAGENS BERMAN IS INVESTIGATING THE ALLEGATIONS.

INSPIRE MEDICAL (INSP) SUED OVER CLAIMS IT MISLED INVESTORS ON NEXT-GENERATION DEVICE LAUNCH -- HAGENS BERMAN

SAN DIEGO , NOV. 26, 2025 /PRNEWSWIRE/ -- COMPANY:INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS A MEDICAL TECHNOLOGY COMPANY. WHAT IS THE CLASS PERIOD?

DID YOU LOSE MONEY IN INSPIRE MEDICAL SYSTEMS, INC.? CONTACT ROBBINS LLP FOR INFORMATION ABOUT RECOVERING YOUR LOSSES

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 26, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

DEADLINE ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF INSPIRE MEDICAL SYSTEMS

INSP INVESTORS WITH LOSSES ENCOURAGED TO CONTACT HAGENS BERMAN SAN FRANCISCO , NOV. 25, 2025 /PRNEWSWIRE/ -- MEDICAL DEVICE MANUFACTURER INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS THE SUBJECT OF A SECURITIES CLASS ACTION LAWSUIT FOLLOWING A SHARP DECLINE IN ITS STOCK PRICE, WITH SHAREHOLDERS ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE LAUNCH OF ITS LATEST PRODUCT, THE INSPIRE V DEVICE FOR OBSTRUCTIVE SLEEP APNEA. HAGENS BERMAN IS INVESTIGATING THE ALLEGATIONS.

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 25, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

SHAREHOLDER ACTION REMINDER: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF INSPIRE MEDICAL SYSTEMS

SAN FRANCISCO, NOV. 24, 2025 (GLOBE NEWSWIRE) -- MEDICAL DEVICE MANUFACTURER INSPIRE MEDICAL SYSTEMS, INC.(NYSE: INSP) IS THE SUBJECT OF A SECURITIES CLASS ACTION LAWSUIT FOLLOWING A SHARP DECLINE IN ITS STOCK PRICE, WITH SHAREHOLDERS ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE LAUNCH OF ITS LATEST PRODUCT, THE INSPIRE V DEVICE FOR OBSTRUCTIVE SLEEP APNEA.

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 24, 2025) - LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) AND CERTAIN OF THE COMPANY'S SENIOR EXECUTIVES FOR SECURITIES FRAUD AFTER A SIGNIFICANT STOCK DROP RESULTING FROM THE POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN INSPIRE, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES/INSPIRE-MEDICAL-SYSTEMS-INC-CLASS-ACTION-LAWSUIT.

INSPIRE NOTICE: INSPIRE MEDICAL SYSTEMS, INC. (INSP) FACES SECURITIES FRAUD ALLEGATIONS AFTER STOCK DROPS 32%, INVESTORS URGED TO CONTACT BFA LAW

SAN FRANCISCO, NOV. 21, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC.(NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL NEXT GENERATION SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

INSPIRE MEDICAL SYSTEMS, INC. (INSP) FACES INVESTOR SUIT OVER DISASTROUS INSPIRE V LAUNCH-- HAGENS BERMAN

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK , NOV. 21, 2025 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

UPCOMING DEADLINE: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF INSPIRE MEDICAL SYSTEMS

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NOV. 20, 2025 (GLOBE NEWSWIRE) -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. (INSPIRE MEDICAL OR THE COMPANY) (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

INSP INVESTOR NOTICE: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF INSPIRE MEDICAL SYSTEMS

INSP INVESTORS WITH LOSSES ENCOURAGED TO CONTACT HAGENS BERMAN SAN FRANCISCO, CALIFORNIA--(NEWSFILE CORP. - NOVEMBER 20, 2025) - INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL "NEXT GENERATION" SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 19, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

SAN FRANCISCO, NOV. 19, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC.(NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL NEXT GENERATION SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

NEW YORK, NOV. 19, 2025 (GLOBE NEWSWIRE) -- LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) AND CERTAIN OF THE COMPANY'S SENIOR EXECUTIVES FOR SECURITIES FRAUD AFTER A SIGNIFICANT STOCK DROP RESULTING FROM THE POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN INSPIRE, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES/INSPIRE-MEDICAL-SYSTEMS-INC-CLASS-ACTION-LAWSUIT.

INSP STOCK: INSPIRE MEDICAL SYSTEMS, INC. SUED FOR SECURITIES FRAUD AFTER INSPIRE V DELAYS CAUSE 32% STOCK DROP -- INVESTORS NOTIFIED TO CONTACT BFA LAW BY JANUARY 5 DEADLINE

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 18, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

INSP INVESTORS WITH LOSSES ENCOURAGED TO CONTACT THE FIRM SAN FRANCISCO , NOV. 18, 2025 /PRNEWSWIRE/ -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL "NEXT GENERATION" SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

MINNEAPOLIS, NOV. 18, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) (INSPIRE), A MEDICAL TECHNOLOGY COMPANY FOCUSED ON THE DEVELOPMENT AND COMMERCIALIZATION OF INNOVATIVE, MINIMALLY INVASIVE SOLUTIONS FOR PATIENTS WITH OBSTRUCTIVE SLEEP APNEA, ANNOUNCED TODAY THAT ITS MANAGEMENT TEAM WILL PRESENT AT THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE ON TUESDAY, DECEMBER 2, 2025. INSPIRE IS SCHEDULED TO PRESENT AT 11:30 A.M.

INSPIRE MEDICAL SYSTEMS, INC. TO PRESENT AT THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE

SAN FRANCISCO, NOV. 17, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC.(NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL NEXT GENERATION SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

INSPIRE MEDICAL SYSTEMS, INC. (INSP) FACES INVESTOR SUIT OVER DISASTROUS INSPIRE V LAUNCH  HAGENS BERMAN

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 15, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

SAN FRANCISCO, NOV. 14, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL NEXT GENERATION SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 14, 2025) - LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) AND CERTAIN OF THE COMPANY'S SENIOR EXECUTIVES FOR SECURITIES FRAUD AFTER A SIGNIFICANT STOCK DROP RESULTING FROM THE POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN INSPIRE, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES/INSPIRE-MEDICAL-SYSTEMS-INC-CLASS-ACTION-LAWSUIT.

INSPIRE MEDICAL SYSTEMS INVESTORS: INSPIRE MEDICAL SYSTEMS, INC. (INSP) HAS BEEN SUED FOR SECURITIES FRAUD, INVESTORS ARE URGED TO CONTACT BFA LAW

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 13, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 13, 2025) - IF YOU SUFFERED A LOSS ON YOUR INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) INVESTMENT AND WANT TO LEARN ABOUT A POTENTIAL RECOVERY UNDER THE FEDERAL SECURITIES LAWS, FOLLOW THE LINK BELOW FOR MORE INFORMATION: HTTPS://ZLK.COM/PSLRA-1/INSPIRE-MEDICAL-SYSTEMS-INC-LAWSUIT-SUBMISSION-FORM?PRID=177137&WIRE=5&UTM_CAMPAIGN=5 OR CONTACT JOSEPH E. LEVI, ESQ.

INVESTORS URGED TO CONTACT LEVI & KORSINSKY FOR INFORMATION BEFORE JANUARY 5, 2026 - INSPIRE MEDICAL SYSTEMS, INC. (INSP)

SAN FRANCISCO--(BUSINESS WIRE)--INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL NEXT GENERATION SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH. PROMINENT INVESTOR RIGHTS LAW FIRM HAGENS BERMAN IS INVESTIGA.

NEW YORK, NOV. 13, 2025 (GLOBE NEWSWIRE) -- LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) AND CERTAIN OF THE COMPANY'S SENIOR EXECUTIVES FOR SECURITIES FRAUD AFTER A SIGNIFICANT STOCK DROP RESULTING FROM THE POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN INSPIRE, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES/INSPIRE-MEDICAL-SYSTEMS-INC-CLASS-ACTION-LAWSUIT.

INSP ALERT: DID INSPIRE MEDICAL SYSTEMS, INC. MISLEAD INVESTORS? BFA LAW REMINDS INVESTORS WITH LOSSES OF THE UPCOMING JANUARY 5 COURT DEADLINE

LEAD PLAINTIFF DEADLINE IS JANUARY 5, 2026 NEW YORK , NOV. 13, 2025 /PRNEWSWIRE/ -- WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLPINFORMS INVESTORS IN INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) ("INSPIRE") THAT A SECURITIES CLASS ACTION HAS BEEN FILED ON BEHALF OF ALL THOSE WHO PURCHASED SHARES BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 (THE "CLASS PERIOD"). INVESTORS HAVE UNTIL JANUARY 5, 2026 TO SEEK APPOINTMENT AS LEAD PLAINTIFF.

SHAREHOLDERS WHO LOST MONEY IN SHARES OF INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) SHOULD CONTACT WOLF HALDENSTEIN IMMEDIATELY

NEW YORK, NOV. 12, 2025 (GLOBE NEWSWIRE) -- WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP REMINDS INVESTORS IN INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) (INSPIRE) SECURITIES THAT A SECURITIES CLASS ACTION HAS BEEN FILED ON BEHALF OF ALL INVESTORS WHO PURCHASED SHARES BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 (THE CLASS PERIOD). INVESTORS HAVE UNTIL JANUARY 5, 2026 TO SEEK APPOINTMENT AS LEAD PLAINTIFF.

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 12, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

INVESTOR DEADLINE APPROACHING: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF INSPIRE MEDICAL SYSTEMS

SAN FRANCISCO, NOV. 11, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC.(NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL NEXT GENERATION SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

INSPIRE MEDICAL SYSTEMS, INC. (INSP) FACES INVESTOR SUIT OVER DISASTROUS INSPIRE V LAUNCH -- HAGENS BERMAN

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN INSPIRE MEDICAL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN INSPIRE MEDICAL BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 10, 2025) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. ("INSPIRE MEDICAL" OR THE "COMPANY") (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

SAN FRANCISCO , NOV. 10, 2025 /PRNEWSWIRE/ -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL "NEXT GENERATION" SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

SAN FRANCISCO, NOV. 08, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) IS NOW GRAPPLING WITH A PROPOSED CLASS-ACTION LAWSUIT ALLEGING THE COMPANY MISLED INVESTORS ABOUT THE COMMERCIAL READINESS AND DEMAND FOR ITS CRITICAL NEXT GENERATION SLEEP APNEA DEVICE, THE INSPIRE V. THE LITIGATION ZEROES IN ON THE DISPARITY BETWEEN THE COMPANY'S CONFIDENT ASSURANCES AND THE SUBSEQUENT DISASTROUS ROLLOUT THAT LED TO A DRAMATIC STOCK CRASH.

NEW YORK--(BUSINESS WIRE)--ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES A CLASS ACTION LAWSUIT ON BEHALF OF PURCHASERS AND ACQUIRERS OF INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) COMMON STOCK BETWEEN AUGUST 6, 2024 AND AUGUST 4, 2025, BOTH DATES INCLUSIVE (THE CLASS PERIOD). INSPIRE MEDICAL IS A MEDICAL TECHNOLOGY COMPANY. FOR MORE INFORMATION, SUBMIT A FORM, EMAIL ATTORNEY PHILLIP KIM, OR GIVE US A CALL AT 866-767-3653. THE ALLEGATIONS: ROSEN LAW FIRM IS INVESTIGATING THE ALL.

ROSEN LAW FIRM URGES INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) STOCKHOLDERS WITH LARGE LOSSES TO CONTACT THE FIRM FOR INFORMATION ABOUT THEIR RIGHTS

NEW YORK--(BUSINESS WIRE)---- $INSP #CLASSACTION--FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST INSPIRE MEDICAL SYSTEMS, INC. (INSPIRE MEDICAL OR THE COMPANY) (NYSE: INSP) AND REMINDS INVESTORS OF THE JANUARY 5, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. FARUQI & FARUQI IS A LEADING NATIONAL SECURITIES LAW FIRM WITH OFFICES IN NEW YORK, PENNSYLVANIA, CALIFORNIA AND.

MINNEAPOLIS, NOV. 03, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) (INSPIRE, OR THE COMPANY), A MEDICAL TECHNOLOGY COMPANY FOCUSED ON THE DEVELOPMENT AND COMMERCIALIZATION OF INNOVATIVE, MINIMALLY INVASIVE SOLUTIONS FOR PATIENTS WITH OBSTRUCTIVE SLEEP APNEA, TODAY REPORTED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025.

INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND UPDATES 2025 OUTLOOK

MINNEAPOLIS, OCT. 27, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) (INSPIRE), A MEDICAL TECHNOLOGY COMPANY FOCUSED ON THE DEVELOPMENT AND COMMERCIALIZATION OF INNOVATIVE, MINIMALLY INVASIVE SOLUTIONS FOR PATIENTS WITH OBSTRUCTIVE SLEEP APNEA, ANNOUNCED TODAY THAT ITS MANAGEMENT TEAM WILL PRESENT AT THE 2025 UBS GLOBAL HEALTHCARE CONFERENCE ON MONDAY, NOVEMBER 10, 2025.

INSPIRE MEDICAL SYSTEMS, INC. TO PRESENT AT THE 2025 UBS GLOBAL HEALTHCARE CONFERENCE

MINNEAPOLIS, OCT. 10, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) (INSPIRE), A MEDICAL TECHNOLOGY COMPANY FOCUSED ON THE DEVELOPMENT AND COMMERCIALIZATION OF INNOVATIVE, MINIMALLY INVASIVE SOLUTIONS FOR PATIENTS WITH OBSTRUCTIVE SLEEP APNEA (OSA), TODAY PUBLISHED INSPIRE V CLINICAL OUTCOMES DATA FROM ITS SINGAPORE CLINICAL STUDY AS WELL AS THE COMPANY'S LIMITED MARKET RELEASE IN THE UNITED STATES INCLUDING SINGLE SITE EXPERIENCE AT TWO LEADING CENTERS. THESE DATA WILL BE PRESENTED AT THE AMERICAN OTOLARYNGOLOGY-HEAD AND NECK SURGERY (AAO-HNS) AND INTERNATIONAL SURGICAL SLEEP SOCIETY (ISSS) MEETINGS BEING CONDUCTED IN INDIANAPOLIS BETWEEN OCTOBER 9 AND OCTOBER 14.

INSPIRE MEDICAL SYSTEMS, INC. PUBLISHES INSPIRE V DATA AT ISSS/AAO-HNS MEETINGS

MINNEAPOLIS, OCT. 06, 2025 (GLOBE NEWSWIRE) -- INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) (INSPIRE) WILL RELEASE FINANCIAL RESULTS FOR THE THIRD QUARTER 2025 AFTER THE CLOSE OF TRADING ON MONDAY, NOVEMBER 3. INSPIRE'S MANAGEMENT TEAM WILL HOST A CORRESPONDING CONFERENCE CALL BEGINNING AT 5:00 P.M.

Inspire Medical Systems, Inc.

INSP

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Inspire Medical Systems, Inc.

INSP.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

INSP